U.S. markets close in 1 hour 33 minutes

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
121.62+1.20 (+1.00%)
As of 2:21PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/27/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
2.03B2.54B1.60B1.53B1.80B
Enterprise Value 3
2.05B2.58B1.26B1.18B1.48B
Trailing P/E
52.20N/A4.97k250.84N/A
Forward P/E 1
19.9226.6016.2317.6132.36
PEG Ratio (5 yr expected) 1
1.331.781.081.172.16
Price/Sales (ttm)
9.5513.2411.5513.2018.89
Price/Book (mrq)
2.723.582.292.212.72
Enterprise Value/Revenue 3
9.8546.8518.0628.3035.76
Enterprise Value/EBITDA 7
24.14104.6655.99-1.49k38.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.19
52-Week Change 3-3.35%
S&P500 52-Week Change 335.08%
52 Week High 3219.75
52 Week Low 378.26
50-Day Moving Average 3125.94
200-Day Moving Average 3141.32

Share Statistics

Avg Vol (3 month) 3152.81k
Avg Vol (10 day) 3105.23k
Shares Outstanding 516.65M
Implied Shares Outstanding 6N/A
Float 15.84M
% Held by Insiders 14.83%
% Held by Institutions 195.73%
Shares Short (Jul 14, 2021) 41.76M
Short Ratio (Jul 14, 2021) 410.54
Short % of Float (Jul 14, 2021) 414.84%
Short % of Shares Outstanding (Jul 14, 2021) 410.56%
Shares Short (prior month Jun 14, 2021) 41.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 01, 2010
Last Split Factor 21:6
Last Split Date 3Nov 18, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 18.83%
Operating Margin (ttm)14.57%

Management Effectiveness

Return on Assets (ttm)1.53%
Return on Equity (ttm)5.58%

Income Statement

Revenue (ttm)208.41M
Revenue Per Share (ttm)12.90
Quarterly Revenue Growth (yoy)66.30%
Gross Profit (ttm)96.61M
EBITDA 65.04M
Net Income Avi to Common (ttm)39.25M
Diluted EPS (ttm)2.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)339.21M
Total Cash Per Share (mrq)20.37
Total Debt (mrq)366M
Total Debt/Equity (mrq)49.07
Current Ratio (mrq)4.57
Book Value Per Share (mrq)44.79

Cash Flow Statement

Operating Cash Flow (ttm)48.42M
Levered Free Cash Flow (ttm)119.44M